About Us

Pangaea Biotechnology LLC is focused primarily on making available innovative and differentiated biotechnology products across the Middle East through distributorship agreements with leading edge manufacturers in the healthcare sector. The company's base of operation is in Amman, Jordan.

We are the exclusive distributors for bio-ConneKt® Wound Matrix, which is an advanced collagen based biologic graft approved by the USFDA as well as the Jordanian FDA (JFDA), for the treatment of chronic and non-healing wounds. The company is in the process of securing approvals in additional countries in the region.

Pangaea Biotechnology’s executive management team and advisors bring extensive experience in global commercialization and operationalization having served in leadership roles at a diverse set of companies across many regions.

bio-ConneKt® Wound Matrix Features

Comprised of extracted and stabilized Type I collagen to prevent premature digestion in wound bed and resist rapid proteolysis.
Biocompatible/cell friendly matrix Sterile & Pyrogen-free. Easily conformable to ensure maximum contact with wound bed.
Hydrophillic scaffold to facilitate rapid fluid absorption (0.5 cc per sq cm of surface area).

Porous matrix to enable optimal host cell infiltration.
Material designed to minimize repeat application
Stored dry at room temperature 4-year shelf-life Ease of use (minimal prep time).
Cleared by the FDA in 2014, and JFDA in 2021.

For more information on bio-ConneKt® please click here: https://mlmbiologics.com/bio-connekt.html

bio-ConneKt® Wound Matrix is a registered Trade Mark of MLM Biologics Inc.